Agios Appoints Cecilia Jones as Chief Financial Officer Read more about Agios Appoints Cecilia Jones as Chief Financial Officer
Agios Receives Positive CHMP Opinion for PYRUKYND® (mitapivat) for the Treatment of Pyruvate Kinase (PK) Deficiency in Adult Patients Read more about Agios Receives Positive CHMP Opinion for PYRUKYND® (mitapivat) for the Treatment of Pyruvate Kinase (PK) Deficiency in Adult Patients
Agios at Wells Fargo Healthcare Conference Read more about Agios at Wells Fargo Healthcare Conference
Agios to Participate in September Investor Conferences Read more about Agios to Participate in September Investor Conferences
Agios Announces Publication of Phase 3 ACTIVATE-T Data in The Lancet Haematology Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency Read more about Agios Announces Publication of Phase 3 ACTIVATE-T Data in The Lancet Haematology Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency
Agios Appoints Rahul Ballal and Cynthia Smith to Board of Directors Read more about Agios Appoints Rahul Ballal and Cynthia Smith to Board of Directors
Agios Announces Publication of Phase 2 Data in The Lancet Demonstrating Safety and Efficacy of PYRUKYND® (mitapivat) in Non-transfusion-dependent α- and β-Thalassemia Read more about Agios Announces Publication of Phase 2 Data in The Lancet Demonstrating Safety and Efficacy of PYRUKYND® (mitapivat) in Non-transfusion-dependent α- and β-Thalassemia
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer Read more about Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer
Agios Reports Business Highlights and Second Quarter 2022 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2022 Financial Results
Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022 Read more about Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022